Fundraising Fox

Novocuff

Mountain View, US · Founded 2022 · Delaware corporation · 11 employees on LinkedIn · 3 known investors

Find your way into Novocuff

399 people in our graph share verified history with the Novocuff team — schools, employers, funds. One of them is your warm intro.

Paul Veradittakitunlockedknows Amelia Degenkolb · together at University of California, Berkeley (overlapped)
×9knows the team · via University of California, Berkeley
knows the team · via University of Massachusetts Amherst
knows the team · via Cal Poly State University

Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.

FemTechHealthtechMedical Devices

Founders & leadership

DLDonald Lee
Donald LeeinCo-Founder & COO
ADAmelia Degenkolb
Amelia DegenkolbinChief Executive OfficerAmelia Degenkolb has worked in product development and regulatory strategy for FDA-regulated medical device companies, with experience in clinical education and cross-functional stakeholder alignment. She is Executive Officer and Director at Novocuff, which develops the investigational Novocuff Cervical Control System to address preterm birth complications.
AD
Amy Degenkolb

Board

LD
Lilly DeSouza BurrBoard director
CL
Curt LaBelleBoard director
RSRebecca Shmukler
Rebecca Shmuklerin𝕏Board MemberPrincipal at Laerdal Million Lives Fund
SPShacey Petrovic
Shacey PetrovicinChairpersonExecutive Officer, Director at Axena Health

Investors · 3

Foreground CapitalBoston
Laerdal Million Lives FundSan Francisco · $1M – $5M
TullisreportedPalm Beach Gardens

Reported raises · per SEC filings

Form D private placements

$6.8M disclosed across 1 round · 2024

▶$6.8MraisedJul 2024 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Shacey PetrovicDirector
  • Donald LeeExecutive Officer
  • Lilly DeSouza BurrDirector
  • Curt LaBelleDirector
  • Rebecca ShmuklerDirector
  • Amelia DegenkolbExecutive Officer, Director
Offering amount
$28M
Amount sold
$6.8M
First sale
Jun 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Novocuff Announces IDE Approval for the RETAIN Studybusinesswire.com · Sep 2025Novocuff Secures $26M in Series A Funding to Advance Preterm Birth Prevention Technology | Femtech Insiderfemtechinsider.com · Jul 2024Novocuff scoops $26m to develop preterm birth prevention devicemedicaldevice-network.com · Jul 2024Novocuff Raises $26 Million in Oversubscribed Series A Funding to Advance Technology Aimed at Reducing Preterm Birthsfinance.yahoo.com · Jul 2024Novocuff Raises $26M in Series A Fundingfinsmes.com · Jul 2024Novocuff Joins FI to Help Prevent Preterm Birth - Fogarty Innovationfogartyinnovation.org · Feb 2024

Frequently asked questions

What does Novocuff do?
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.
Who are Novocuff's investors?
Novocuff's investors include Foreground Capital, Laerdal Million Lives Fund, Tullis.
How much funding has Novocuff raised?
Novocuff has disclosed $6.8M raised across 1 round.
Where is Novocuff headquartered?
Novocuff is headquartered in Mountain View, US.